People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pelthos Therapeutics Inc. | — | Pharmaceuticals | Series C | $98.8M | $98.6M | 2024 |
Eric Lang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric Lang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Todd Davis | 1 | 8 |
| Francis Knuettel II | 1 | 5 |
| Matthew Pauls | 1 | 4 |
| Peter Greenleaf | 1 | 3 |
| Ezra Friedberg | 1 | 2 |
| Chia-Lin Simmons | 1 | 2 |
| Richard Baxter | 1 | 1 |
| Sai Rangarao | 1 | 1 |
| Scott Plesha | 1 | 1 |
| Francis Knuettel | 1 | 1 |
| Richard Malamut | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.